Team identifies the novel molecular signal for triggering septic shock

KAIST team identifies the novel molecular signal for triggering septic shock
The deletion of IPMK (inositol polyphosphate multikinase) in macrophages reduces the stability of TRAF6 protein which is the key to innate immune signaling, thereby blocking excessive inflammation in response to pathological bacterial infection. Credit: KAIST

Professor Seyun Kim's team from KAIST reported the mechanism by which cellular signaling transduction network is exquisitely controlled in mediating innate immune response such as sepsis by the enzyme IPMK (Inositol polyphosphate multikinase) essential for inositol biosynthesis metabolism.

In collaboration with Professor Rho Hyun Seong at Seoul National University, the study's first author, Eunha Kim, a Ph.D. candidate in Department of Biological Sciences, performed a series of cellular, biochemical, and physiological experiments searching for the new function of IPMK enzyme in macrophages. The research findings were published in Science Advances on April 21.

Professor Kim's team has been investigating various metabolites and their biosynthesis metabolism for several years and has multilaterally identified signaling actions of IPMK (Inositol polyphosphate multikinase) in the control of cellular growth and energy homeostasis.

This research showed that specific deletion of IPMK enzyme in macrophages could significantly reduce levels of inflammation and increase survival rates in mice when they were challenged by microbial septic shock as well as endotoxins. This suggests a role for IPMK enzyme in mediating innate inflammatory responses that are directly related to host defense against pathogenic bacterial infection.

The team further discovered that IPMK enzyme directly binds to TRAF6 protein, a key player in immune signaling, thus protecting TRAF6 protein from ubiquitination reactions that are involved in protein degradation. In addition, Kim and colleagues successfully verified this IPMK-dependent immune control by employing short peptides which can specifically interfere with the binding between IPMK enzyme and TRAF6 in macrophage cells.

This research revealed a novel function of IPMK in the fine tuning of innate immune signaling networks, suggesting a new direction for developing therapeutics targeting serious medical conditions such as neuroinflammation, type 2 diabetes, as well as polymicrobial sepsis that are developed from uncontrolled host immune responses. This research was funded by the Ministry of Science, ICT and Future Planning.


Explore further

Epigenetic enzyme found to be lacking in some patients with Crohn's disease

More information: Eunha Kim et al, Inositol polyphosphate multikinase promotes Toll-like receptor–induced inflammation by stabilizing TRAF6, Science Advances (2017). DOI: 10.1126/sciadv.1602296
Journal information: Science Advances

Citation: Team identifies the novel molecular signal for triggering septic shock (2017, May 4) retrieved 20 September 2019 from https://medicalxpress.com/news/2017-05-team-molecular-triggering-septic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more